Total Payments
$10,490
2024 Payments
$1,455
Companies
42
Transactions
536
Medicare Patients
12,017
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$10,416 (99.3%)
Education$73.62 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,416 | 531 | 99.3% |
| Education | $73.62 | 5 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,073 | 55 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $955.32 | 61 | $0 (2024) |
| Abbott Laboratories | $854.38 | 22 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $799.19 | 45 | $0 (2024) |
| Boston Scientific Corporation | $664.18 | 17 | $0 (2024) |
| Lundbeck LLC | $639.99 | 29 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $588.24 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $463.40 | 26 | $0 (2024) |
| Esperion Therapeutics, Inc. | $401.32 | 24 | $0 (2024) |
| PFIZER INC. | $367.24 | 24 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,455 | 57 | Amgen Inc. ($233.56) |
| 2023 | $1,175 | 56 | Merck Sharp & Dohme LLC ($192.10) |
| 2022 | $1,427 | 67 | Amgen Inc. ($180.27) |
| 2021 | $993.37 | 59 | Esperion Therapeutics, Inc. ($176.68) |
| 2020 | $974.89 | 59 | Amarin Pharma Inc. ($149.16) |
| 2019 | $1,323 | 70 | Lundbeck LLC ($199.95) |
| 2018 | $1,674 | 77 | Abbott Laboratories ($462.14) |
| 2017 | $1,467 | 91 | Janssen Pharmaceuticals, Inc ($219.94) |
All Payment Transactions
536 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $35.74 | General |
| Category: Cardiology | ||||||
| 12/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $40.83 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/19/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiovascular Diseases | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.81 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/23/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Not Applicable | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.22 | General |
| Category: Cardiology | ||||||
| 09/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: CDS - BG Mini Plus_RM | ||||||
| 08/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.25 | General |
| Category: Cardiovascular | ||||||
| 07/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Cardiology | ||||||
| 07/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,894 | 4,800 | $1.7M | $374,426 |
| 2022 | 25 | 3,257 | 4,382 | $1.7M | $392,860 |
| 2021 | 19 | 3,055 | 3,804 | $1.6M | $384,622 |
| 2020 | 22 | 2,811 | 3,390 | $1.3M | $309,714 |
Total Patients
12,017
Total Services
16,376
Medicare Billing
$1.5M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 856 | 1,349 | $337,250 | $82,864 | 24.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 195 | 195 | $429,000 | $66,972 | 15.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 365 | 385 | $327,250 | $54,450 | 16.6% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 195 | 196 | $40,853 | $31,742 | 77.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 344 | 349 | $92,136 | $16,870 | 18.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 119 | 121 | $54,450 | $16,600 | 30.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 89 | 356 | $39,160 | $14,938 | 38.1% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 35 | 463 | $44,448 | $14,558 | 32.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 37 | 345 | $40,710 | $13,166 | 32.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 190 | $47,500 | $12,130 | 25.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 37 | 279 | $36,828 | $10,659 | 28.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 85 | 98 | $25,480 | $9,949 | 39.0% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 44 | 44 | $44,000 | $8,467 | 19.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 96 | 96 | $33,600 | $7,682 | 22.9% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 21 | 21 | $21,000 | $4,111 | 19.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 20 | 20 | $40,000 | $4,044 | 10.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 52 | 56 | $16,800 | $2,966 | 17.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 192 | 209 | $16,720 | $1,982 | 11.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 28 | 28 | $1,260 | $276.21 | 21.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 196 | 196 | $431,200 | $71,363 | 16.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 666 | 930 | $232,500 | $57,974 | 24.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 347 | 356 | $302,050 | $54,797 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 320 | 353 | $105,900 | $31,159 | 29.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 155 | 157 | $32,473 | $25,266 | 77.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 134 | 141 | $63,100 | $20,889 | 33.1% |
About Dr. Mobeen Mazhar, M.D
Dr. Mobeen Mazhar, M.D is a Cardiovascular Disease healthcare provider based in Cypress, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689768277.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mobeen Mazhar, M.D has received a total of $10,490 in payments from pharmaceutical and medical device companies, with $1,455 received in 2024. These payments were reported across 536 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($10,416).
As a Medicare-enrolled provider, Mazhar has provided services to 12,017 Medicare beneficiaries, totaling 16,376 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Cypress, TX
- Active Since 10/03/2006
- Last Updated 01/20/2026
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689768277
Products in Payments
- XARELTO (Drug) $955.32
- Repatha (Biological) $910.37
- ELIQUIS (Drug) $803.24
- NORTHERA (Drug) $639.99
- ENTRESTO (Drug) $568.38
- VERQUVO (Drug) $463.40
- NEXLETOL (Drug) $382.52
- LifeVest (Device) $358.00
- Ozempic (Drug) $262.38
- WATCHMAN FLX (Device) $248.46
- Merlin Connectivity and Remote (Device) $239.77
- Vascepa (Drug) $234.59
- LEQVIO (Drug) $230.81
- BRILINTA (Drug) $226.46
- WATCHMAN Access System (Device) $210.72
- MULTAQ (Drug) $201.83
- ZONTIVITY (Drug) $184.26
- OPSUMIT (Drug) $166.57
- PRALUENT (Drug) $163.95
- Corlanor (Drug) $162.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Cypress
Dr. Kuldeep Talwar, Md, MD
Cardiovascular Disease — Payments: $20,584
Cardiovascular Disease $20,584
Dr. John Nguyen, M.d, M.D
Cardiovascular Disease — Payments: $11,756
Cardiovascular Disease $11,756
Dr. Cyril Tawa, M.d, M.D
Cardiovascular Disease — Payments: $10,796
Cardiovascular Disease $10,796
Dr. Peter Razeghi, M.d, M.D
Cardiovascular Disease — Payments: $6,075
Cardiovascular Disease $6,075
Zohair Hasan, Md, MD
Cardiovascular Disease — Payments: $5,571
Cardiovascular Disease $5,571
Attiya Khan, M.d, M.D
Cardiovascular Disease — Payments: $4,321
Cardiovascular Disease $4,321